Our experience positions us to understand entrepreneurs, the business opportunity and drives our active role in creating value within our portfolio companies. With each individual investment, we carefully define business strategy with an eye to an exit; we build the business plan with entrepreneurs and actively manage execution, integrating with the company as an extension of the operating team. Our investment focus is on patient-centric innovations within life sciences. In particular, we look for proprietary, differentiated therapeutic products addressing high-unmet medical need and platform technologies supporting next-generation patient diagnosis, treatment and disease prevention.

We source opportunities globally, primarily from industry, start-up communities and business accelerators. Our hands-on approach shapes each investment opportunity towards its business potential with a 3-5 year runway to strategic partnerships, acquisition by large life science companies or an IPO.

Ventac Capital has a deep global network for sourcing, deal making and talent acquisition, inclusive of Ventac Partners, see www.ventac-partners.com , and other international experts. We strive to maximize shareholder returns for all portfolio companies with our capital efficient model and shorter time to realization.